Companies/Hyperion DeFi, Inc.

Company profile

Hyperion DeFi, Inc.

NASDAQ: HYPD · Healthcare · Medical - Devices

PublicHQ New York, NY · New YorkCIK 0001682639Reports USD

#887 of 1,418 Healthcare companies by revenuetop-decile growth

EA Score

35D

FH 41DQ 26GM 40SS 29

v0.1 · 65/100 weight · provisional

↑ revenue growth (YoY), balance-sheet leverage · ↓ listing tenure, growth stability

Methodology →

Revenue TTM

$1.4M

Rev growth YoY (TTM)

+3052.0%

Net income (FY)

-$45.3M

Employees

as of 2026-08-21

Market cap

$47.6M

as of 2026-08-21

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Revenue$813.5k$813.5k2025

Net income-$45.3M-$45.3M2025

Operating income-$46.7M-$46.7M2025

Total assets$51.8M$51.8M2025

Liabilities$10.7M$10.7M2025

Equity$41.1M$41.1M2025

Revenue trend

FY2020 – FY2025 · USD

$2.0M

FY20

$14.0M

FY21

$3.8k

FY23

$57.3k

FY24

$813.5k

FY25

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

What is Hyperion DeFi, Inc.’s revenue?

Hyperion DeFi, Inc. booked $813.5k in FY2025 revenue, growing 1319% year over year — faster than 97% of Healthcare companies we track, at a -5570.6% net margin.

Peers · Healthcare

Imagenetix, Inc.——Catheter Precision, Inc.39D Onconetix, Inc.25D Helix BioMedix, Inc.56C ImageneBio Inc48D BioCorRx Inc.44D

Neighbors

New York →

JPMorgan Chase & Co.$182.4B72B Morgan Stanley$34.3B61C The Goldman Sachs Group, Inc.——Philip Morris International Inc.$40.6B86A American Express Company$41.3B78B+Citigroup Inc.$85.2B55C

Key facts

CEOHyunsu Jung

SectorHealthcare

IndustryMedical - Devices

HeadquartersNew York, NY

ExchangeNASDAQ: HYPD

Employees9

IPO date2025-07-02

Latest filings

10-Q2026-08-13 8-K2026-08-12 8-K2026-07-08 8-K2026-07-01 8-K2026-06-05 10-Q2026-05-15 8-K2026-05-14 8-K2026-05-06

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.